Dr David McIntyre Describes the Intersection Between Covid-19, Obesity, and Gestational Diabetes

August 2nd 2021, 3:00pm


David McIntyre, MD, FRACP, outlines how metabolic factors could impact the severity of COVID-19 infections among pregnant people.

Outcomes-Based Agreements Give New Insight for Treatment of Diabetes and Cardiovascular Disease

July 28th 2021, 1:00pm


Dr Deepak Bhatt on the Potential Stroke Benefits of SGLT1s

July 27th 2021, 6:45pm


Deepak L. Bhatt, MD, MPH, executive director of interventional cardiovascular programs at Brigham and Women’s Hospital Heart & Vascular Center and professor of medicine at Harvard Medical School, discusses whether sodium glucose co-transporter 1 (SGLT1) inhibitors can yield stroke benefits in patients with type 2 diabetes.

Biking Linked With Reduced All-Cause, CVD Mortality Among Patients With Diabetes

July 22nd 2021, 1:00pm


New research shows that independent of other forms of physical activity, biking is associated with reduced mortality rates among adults with diabetes.

Catlin Dennis Explains Challenges Vulnerable Youth With Diabetes Faced During COVID-19

July 20th 2021, 11:30am


Catlin Dennis, MPH, describes the challenges socially and medically vulnerable youth with diabetes and their families faced during the COVID-19 pandemic.

Dr Michelle Litchman Outlines the Benefits of Online Diabetes Peer Support Groups

July 14th 2021, 4:05pm


Michelle Litchman, PHD, FNP-BC, FAANP, FADCES, an assistant professor at the College of Nursing at the University of Utah, describes the results of a study that looked at diabetes technology use and online peer support systems among Spanish-speaking patients. Findings showed that when these 2 interventions are used in conjunction, a positive feedback loop forms.

Study Details Prediabetes, MACE Link

July 11th 2021, 4:20pm


Patients with prediabetes are at significantly higher risk of major cardiovascular events than those who have never had high blood sugar.

Dr David McIntyre Discusses Prevalence of Gestational Diabetes

July 10th 2021, 12:00pm


David McIntyre, MD, FRACP, describes different methods of diagnosing gestational diabetes around the world.

EMPEROR-Preserved First Trial to Show Positive Results in HFpEF

July 7th 2021, 3:35pm


A statement from the makers of the SGLT2 inhibitor empagliflozin suggests the benefits in heart failure with preserved ejection fraction (HFpEF) are significant.

CRL Issued for Provention Bio's T1D Drug Teplizumab

July 6th 2021, 3:29pm


The FDA issued a Complete Response Letter, halting Provention Bio's type 1 diabetes prevention drug.